MaxorPlus Insights
Read the most recent quarterly reports on new drugs coming down the pipeline.
Our Latest Insights
2023 Insights Report
Learn more about the top industry and pharmacy trends driving pharmacy plan spend in 2024 and how Maxor’s clinical programs can help.
GLP-1
GLP-1 medications continue to shape pharmacy trends. Learn more about what is behind the growth of GLP-1 medications used to treat diabetes and weight management.
Download Report
Biosimilars
The biosimilar landscape is quickly evolving with the addition of new therapies, allowing for better access, more choice, and lower costs.
Download Report
Cell and Gene Therapy
Cell and gene therapies are transforming the treatment landscape for many diseases, especially for those which have no effective therapies.
Download Report
Our Latest Pipelines
Q4 2024 Pipeline Report
Learn about new therapies in the pipeline that can enhance treatment options, with a spotlight on atopic dermatitis.
Learn more about how we can improve your pharmacy experience
Industry News
What do you need to know about drug shortages?
The Center for Drug Evaluation and Research (CDER) manages drug shortages and works to ensure access to medicines.
Changes in obesity care with the rise of GLP-1s
With an increase in obesity levels in the U.S., there has been a shift in care as GLP-1 use climbs.
Could a nasal spray be used to treat Alzheimer’s disease?
Researchers have developed a nasal spray that targets microglia and astrocytes to delay the progression of the disease.
